This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
News: FHSC

Putting FH on the health agenda - Publications, resources & tools for clinicians

Wednesday 20 September 2017   (0 Comments)
Share |

Publications, resources & tools on FH for clinicians

September 24 is the International FH-awareness day. All this week, in a series of newsletters, EAS highlights activities to raise the awareness of FH. In this newsletter, we focus on how EAS and the FH Studies Collaboration are working on raising awareness of FH in the medical community through publications and online resources.

Guidelines & Consensus publications, Advanced Courses, Congress symposia and other meetings, apps and other online resources

The ESC/EAS guidelines on management of dyslipidaemias (2016), containing sections on Familial Hypercholesterolaemia (Heterozygous FH, Homozygous FH, and FH in children) is the latest essential reference for clinicians. EAS Consensus Position papers on FH (FH in children and adolescents, Homozygous FH, and FH is underdiagnosed and undertreated in the general population) have been widely cited. With a programme of Advanced Courses, Congress symposia and other meetings, and through the apps and other online resources, EAS educates healthcare professionals in the diagnosis and management of FH patients.

Consensus position statements & other papers


Slide sets

For an overview of all the FH related publications, slidesets, apps and other tools visit the FHSC web.

Click here >>

Apps and other tools

Clinician's handbook - Targeting Familial Hypercholesterolaemia

Familial hypercholesterolaemia (FH) is the most common inherited metabolic condition, affecting about one in 200 people. As highlighted by the European Atherosclerosis Society (EAS) Consensus Panel, FH is seriously underdiagnosed and undertreated. This App, authored by members of the Panel, provides an important resource to tackle these issues. Detection, diagnosis, screening and management of FH are discussed, with emphasis on targeting children with FH to optimise benefit and reduce premature heart disease.

Supported by an Unrestricted Educational Grant from SANOFI and REGENERON.

App for iPad and iPhone

Diagnostic support tool - FH Score

Calculate your patient's familial hypercholesterolaemia score

FH Score is a diagnosis support tool for use by healthcare professionals to support the diagnosis of adult patients at risk of heterozygous familial hypercholesterolaemia (HeFH), based on the EAS 2013 Consensus Statement on FH.

FH Score is currently certified as a medical device for use inUK, Germany, Switzerland, France and Belgium, and is available in English, German, French, Italian and Dutch. It is intended to extend the certification for use to further EU countries in the near future.

FH Score

FH diagnosis calculator

The Hellenic Atherosclerosis Society has developed a free FH diagnosis calculator tool that can be downloaded following these links

App Store:
Google Store:

For an overview of all the FH related publications, slidesets, apps and other tools visit the FHSC web.

Click here >>

Membership Software Powered by YourMembership  ::  Legal